Magnesium L-Threonate for the Brain: Is the Premium Worth It?

Magnesium L-threonate was engineered at MIT to raise brain magnesium concentrations. The animal data is genuinely striking, but only one published human randomized trial exists and it has serious limitations. For most cognitive complaints, a generic magnesium glycinate at one-fifth the cost will deliver an equivalent night-of-sleep effect. The threonate premium is justified for a narrow subset of users — and even then, the brain-penetration claim outpaces what the human evidence has actually shown.

The MIT origin story

In 2010, Slutsky and colleagues at MIT published a paper in Neuron showing that a novel magnesium compound — magnesium threonate — raised cerebrospinal fluid magnesium in rats by roughly 15 percent, while older forms (citrate, glycinate, sulfate) did not. The same paper showed enhanced synaptic plasticity, NMDA receptor density, and spatial memory in aged rats. The compound was patented and licensed to a single supplier, which is why every brand calling itself "Magtein" sources from the same manufacturer.

The mechanistic story is plausible. Magnesium is a co-gating ion at the NMDA receptor, and brain magnesium does decline with age. Whether the threonate-bound version uniquely raises brain levels in humans — or merely raises serum magnesium that is then transported normally — has never been demonstrated by direct CSF measurement in a human trial.

The single human RCT

Liu and colleagues published the only randomized trial in 2016, enrolling 44 adults aged 50–70 with subjective cognitive complaints. Participants received 1.5–2 g/day of magnesium L-threonate (delivering ~144 mg elemental magnesium) or placebo for 12 weeks. The treatment group showed improvements on a composite cognitive score equivalent to "9 years younger" performance. The study was funded by Magceutics, the patent holder, with multiple authors as employees or shareholders. Sample size was small, dropout was substantial, and the primary outcome appears to have been changed during the trial.

A 2022 trial from China replicated some of the cognitive findings in 109 older adults. A 2023 Australian trial in healthy young adults showed no effect on working memory or reaction time. There is no published RCT in Alzheimer's, MCI, or any clinical population. The 2024 systematic review by Pickering et al. concluded the evidence for cognitive benefit was "promising but insufficient" to recommend over cheaper magnesium forms.

What threonate actually does at typical doses

The standard dose — 2 g/day of magnesium L-threonate — delivers about 144 mg of elemental magnesium. Compare this to a 400 mg magnesium glycinate capsule, which delivers ~80 mg elemental magnesium per cap, or a 500 mg magnesium citrate dose, which delivers ~85 mg. To match elemental magnesium content, you need roughly two capsules of glycinate per dose of Magtein.

Many users who try threonate report better sleep and "calmer thinking." This is consistent with what a magnesium-deficient or borderline-magnesium person experiences from any well-absorbed magnesium form. Distinguishing a brain-specific threonate effect from a generic magnesium-repletion effect requires comparing threonate to an equivalent elemental dose of glycinate or citrate. No published trial has done this head-to-head comparison rigorously.

When threonate may genuinely be worth the premium

Two scenarios make threonate defensible. First, people with documented mild cognitive impairment whose physician supports a 12-week trial — the Liu protocol is the only published precedent. Second, users who are already replete on serum magnesium (above 0.85 mmol/L) but still experience anxiety, sleep fragmentation, or cognitive fog — in which case the question is whether a more brain-penetrant form helps. Both use cases sit in evidence-light territory.

For the much larger population of people with poor sleep, muscle cramps, anxiety, or constipation tied to sub-optimal magnesium intake, glycinate, taurate, or citrate at 200–400 mg elemental per day is the appropriate first step. These cost roughly $0.10 per dose versus $0.80–$1.20 per dose for threonate.

Practical guidance

If you decide to try threonate, the dose used in the Liu trial is 1.5–2 g/day of the threonate compound (as Magtein), split into morning and evening doses. Expect 8–12 weeks before drawing conclusions. Do not stack with a high-dose generic magnesium — total elemental magnesium should stay under 350 mg/day from supplements (the upper limit set by the Institute of Medicine to avoid GI side effects). Threonate has no known serious interactions but, like all magnesium forms, can reduce absorption of bisphosphonates, fluoroquinolones, and tetracyclines if taken simultaneously.

The most defensible position on threonate today: a clever compound, a plausible mechanism, and a single industry-funded human trial. Until an independent replication appears, it remains a premium product priced as if the evidence were settled. It is not.